2023-07-20 08:17:54 ET
- Longeveron ( NASDAQ: LGVN ) has appointed Lisa Locklear as Executive Vice President and CFO, effective as of July 31, 2023.
- Ms. Locklear joins Longeveron from Avanir Pharmaceuticals, a subsidiary of Otsuka, where she served as Senior Vice President and CFO.
- “I am eager to collaborate with Wa’el, my colleagues on our leadership team, and our Board of Directors to establish a strong financial foundation for Longeveron and help realize this asset’s full potential.” said Lisa Locklear.
For further details see:
Longeveron appoints Lisa Locklear as CFO